# Chongqing Zhifei Biological Products Co., Ltd.

> company which engages in the research, development, manufacture, and marketing of vaccines in China

**Wikidata**: [Q105904156](https://www.wikidata.org/wiki/Q105904156)  
**Source**: https://4ort.xyz/entity/chongqing-zhifei-biological-products-co-ltd-q105904156

## Summary
Chongqing Zhifei Biological Products Co., Ltd. is a public company based in the People's Republic of China that specializes in the vaccine industry. The company engages in the research, development, manufacture, and marketing of vaccines and is listed on the Shenzhen Stock Exchange.

## Key Facts
*   **Entity Type:** The company is classified as both a general company and a public company.
*   **Location:** It operates within the People's Republic of China.
*   **Industry Focus:** The company is primarily engaged in the research, development, manufacture, and marketing of vaccines.
*   **Stock Listing:** The company's securities are traded on the Shenzhen Stock Exchange under the ticker symbol "300122".
*   **Official Name:** The company is also known by its Chinese alias, 重慶智飛生物製品股份有限公司.
*   **Identifiers:** It is tracked with the Google Knowledge Graph ID `/g/1dvbbbt8`.

## FAQs
**What does Chongqing Zhifei Biological Products Co., Ltd. do?**
The company focuses on the vaccine sector, handling the research, development, manufacture, and marketing of biological products within China.

**Where is Chongqing Zhifei Biological Products Co., Ltd. traded?**
The company is a publicly traded entity listed on the Shenzhen Stock Exchange, where it trades under the stock code 300122.

**What is the legal status of Chongqing Zhifei Biological Products Co., Ltd.?**
It is a public company, meaning it offers its securities for sale to the general public, and is incorporated in the People's Republic of China.

## Why It Matters
As a public company, Chongqing Zhifei Biological Products Co., Ltd. plays a significant role in the healthcare sector of the People's Republic of China. Its operations cover the full lifecycle of vaccine production—from research and development to manufacturing and marketing—making it a contributor to public health infrastructure and disease prevention. By being listed on the Shenzhen Stock Exchange, it allows the general public to participate in the financial growth of the biotechnology sector.

## Notable For
*   Engaging in the comprehensive vaccine production lifecycle, including research, development, manufacturing, and marketing.
*   Being a publicly listed entity on the Shenzhen Stock Exchange (ticker: 300122).
*   Operating specifically within the biological products industry in the People's Republic of China.

## Body
### Corporate Identity and Classification
Chongqing Zhifei Biological Products Co., Ltd. is formally recognized as a company and holds the specific classification of a public company. This status indicates that the entity offers its securities for sale to the general public. The company is registered and operates within the jurisdiction of the People's Republic of China. It is also identified by its Chinese name, 重慶智飛生物製品股份有限公司.

### Business Operations
The core business of Chongqing Zhifei Biological Products Co., Ltd. is centered on the vaccine industry. Its operations are comprehensive, encompassing four main activities:
*   **Research:** Investigating new vaccine technologies and products.
*   **Development:** Moving vaccines from the conceptual stage to usable products.
*   **Manufacture:** The physical production of vaccine supplies.
*   **Marketing:** The distribution and sale of these biological products within the Chinese market.

### Financial Listing
The company is listed on the Shenzhen Stock Exchange. This listing is associated with the specific stock code or ticker symbol "300122". As a public company, its securities are available for trading by the general public on this exchange.